Hillsdale Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-373,600	Closed	-$3.11M	–	590
2020 Q2	$3.11M	Buy	+373,600	New	+$3.11M	0.28%	107
2017 Q2	–	Sell	-9,200	Closed	-$159K	–	477
2017 Q1	$159K	Buy	+9,200	New	+$159K	0.03%	283